Feature Channels: AIDS and HIV

Filters close
Released: 22-Nov-2023 1:05 AM EST
مكافحة مرض نقص المناعة البشري المكتسب (الإيدز): لماذا يكمن هدفنا في اكتشاف فيروس نقص المناعة البشري قبل ظهور الأعراض
Mayo Clinic

روتشستر، مينيسوتا – إن فيروس نقص المناعة البشري، الذي يسبب الإيدز (مرض نقص المناعة البشري المكتسب) بإمكانه أن يختفي في الجسم عدة سنوات قبلما تظهر الأعراض. وخلال هذا الوقت، فإنه يقضي على جزء من الجهاز المناعي دون أن نشعر. لذا فإن هدفنا هو اكتشاف فيروس نقص المناعة البشري قبلما تظهر الأعراض، مما يجعل الاختبارات الروتينية ضروريةً كي يعرف المرضى أنهم مصابون وكي يتسنى علاجهم، وهذا ما أوضحته الدكتورة ستيسي ريزا خبيرة الأمراض المُعدية والباحثة في فيروس نقص المناعة البشري لدى مايو كلينك.

Released: 21-Nov-2023 3:45 PM EST
It's not over until it's over. Keep up with the latest COVID research in the Coronavirus channel.
Newswise

Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.

Released: 15-Nov-2023 3:05 AM EST
Another step toward the HIV-1 vaccine: Dynamics of neutralizing antibodies
University of Cologne

An international team has for the first time researched the longevity of neutralizing antibodies in HIV-1-infected people. Currently, it is assumed that an HIV-1 vaccine can only be effective if it produces these antibodies in vaccinated humans.

Newswise:Video Embedded what-you-need-to-know-taking-doxycycline-for-safer-sex
VIDEO
Released: 2-Nov-2023 11:05 AM EDT
What You Need to Know: Taking Doxycycline for Safer Sex
Cedars-Sinai

As the number of sexually transmitted infections (STIs) sharply rises in the U.S., new evidence suggests that a common antibiotic—doxycycline—could help prevent the spread of some bacterial infections.

Newswise: NIH grants support UCLA and Charles Drew University researchers' efforts to end HIV epidemic
Released: 2-Nov-2023 6:00 AM EDT
NIH grants support UCLA and Charles Drew University researchers' efforts to end HIV epidemic
University of California, Los Angeles (UCLA), Health Sciences

The National Institutes of Health (NIH) has granted $2.1 million to UCLA’s Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) and the UCLA-CDU Center for AIDS Research (CFAR) to support four research projects and an implementation science consultation hub.

Newswise: Fiber, the Gut, Heart Disease and HIV
Released: 1-Nov-2023 7:05 PM EDT
Fiber, the Gut, Heart Disease and HIV
Cedars-Sinai

Investigators from Cedars-Sinai have made two important discoveries about fiber and the gut microbiome in patients with human immunodeficiency virus, or HIV.

Released: 1-Nov-2023 4:05 PM EDT
Pet ownership may contribute to health care barriers for people with HIV
University of Florida

People living with HIV may face hard choices when balancing their own health needs with caring for a pet, a study led by a University of Florida College of Public Health and Health Professions researcher finds.

Newswise: Integrated chronic care in Africa can improve outcomes and save money
Released: 9-Oct-2023 5:05 AM EDT
Integrated chronic care in Africa can improve outcomes and save money
La Trobe University

Across Africa about two million premature deaths each year are caused by the effects of diabetes and hypertension.

Newswise: $2.9M NIH grant awarded to Cizik School of Nursing researcher to fund real-time HIV prevention and substance use reduction strategies
Released: 5-Oct-2023 5:05 PM EDT
$2.9M NIH grant awarded to Cizik School of Nursing researcher to fund real-time HIV prevention and substance use reduction strategies
University of Texas Health Science Center at Houston

A four-year, $2.9 million grant to assess the implementation of real-time health intervention to decrease substance use and support HIV prevention strategies in young adults experiencing homelessness.

Released: 3-Oct-2023 6:05 AM EDT
Pharmacists can improve access to life-saving vaccines
University of Waterloo

HPV, or human papillomavirus, is the most common sexually transmitted infection. It is also the leading cause of cervical cancer. Over 1,400 Canadian women are affected yearly, with almost 400 deaths, according to the Canadian Cancer Society.

Released: 27-Sep-2023 12:50 PM EDT
Stay informed on women's health issues in the Women's Health channel
Newswise

Below are some of the latest headlines in the Women's Health channel on Newswise.

Newswise: Discovery highlights need for new approach to STI vaccine
Released: 19-Sep-2023 12:05 PM EDT
Discovery highlights need for new approach to STI vaccine
University of Delaware

University of Delaware researchers conducted exhaustive studies of human papillomavirus (HPV), the most common sexually transmitted infection (STI) in the world. They confirmed 25 different types of HPV prevalent in Nigeria, a discovery that underscores the need for more region-specific vaccines.

Released: 13-Sep-2023 2:05 PM EDT
Studies on Mobile Health Intervention Suggest Positive Impact for Black Same Gender–Loving Men
Rutgers University-New Brunswick

The mobile application, iTHRIVE 365, is the first of its kind to provide psychological health resources, connections to economic support and a safe social space created by and for Black gay, bisexual and other same gender–loving men.

Released: 12-Sep-2023 10:05 AM EDT
Mount Sinai Awarded $3.4 Million to Study Prostate Cancer in People With HIV
Mount Sinai Health System

The National Cancer Institute has awarded the Icahn School of Medicine at Mount Sinai a $3.4 million grant to create a model that identifies the best prostate cancer treatment for people with HIV.

Released: 12-Sep-2023 10:05 AM EDT
HIV: two autopsies reveal where the virus hides
Universite de Montreal

A research team shows for the first time that HIV reservoirs are concentrated in the spleen and lymph nodes, and that they can travel throughout the body.

Released: 6-Sep-2023 10:30 AM EDT
Beauty salon–based intervention increases trust of PrEP among Black cisgender women
Wolters Kluwer Health: Lippincott

Among African American and other Black cisgender women, a beauty salon–based intervention improved knowledge and awareness of pre-exposure prophylaxis (PrEP) against HIV and increased trust in it.

Released: 17-Aug-2023 10:00 AM EDT
Moffitt Awarded $5.5 Million to Study Virus-Associated Tumors Among Those Living with HIV in Sub-Saharan Africa
Moffitt Cancer Center

The Center for Immunization and Infection Research in Cancer at Moffitt Cancer Center is expanding its viral infection research in Africa. The cancer center has received a $5.5 million, five-year specialized research center grant (U54CA277834) from the National Cancer Institute to investigate virus-associated tumors that disproportionately impact men and women living with HIV in sub-Saharan Africa.



close
2.16192